FDA approves first twice-yearly injection that prevents HIV infection
|
The FDA has approved Yetzugo, Gilead Sciences'
twice-yearly injectable HIV prevention treatment, which showed nearly
100% effectiveness in ... |
FDA slaps clinical hold on multiple Gilead HIV trials
Gilead has been hit with a clinical hold from the FDA for five tests of its experimental HIV combination treatment amid safety concerns. View article...